Looks like you clickedhttps://www.urotoday.com/conference-highlights/asco-gu-2022/asco-gu-2022-prostate-cancer/135411-asco-gu-2022-updated-biomarker-results-from-a-phase-1-2-study-of-olaparib-and-radium-223-in-men-with-metastatic-castration-resistant-prostate-cancer-mcrpc-with-bone-metastases-comrade.html
If you do not want to visit that page, you can close this browser tab.
